CeriBell, Inc. CBLL NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score

55/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CeriBell, Inc. (CBLL) has a negative trailing P/E of -13.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -7.68%.

Criteria proven by this page:

VALUE (96/100, Pass) — analyst target implies upside (+46.1%).
Trailing Earnings Yield -7.68% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
Analyst consensus target $30.00 (+46.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

55/100

SG Score

View full scorecard →

✓

VALUE

96/100

Price-to-Earnings & upside

Proven by this page

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

MOAT

56/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CBLL

Valuation Multiples

P/E (TTM)-13.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio4.48

P/S Ratio7.89

EV/EBITDA-13.6

Per Share Data

EPS (TTM)$-1.44

Book Value / Share$4.17

Revenue / Share$2.39

FCF / Share$-1.12

Yields & Fair Value

Earnings Yield-7.68%

Dividend Yield0.00%

Analyst Target$30.00 (+46.1%)

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2022	-15.7	0.00	-6.75	22.49	-
2023	-19.8	0.95	-5.19	12.89	-
2024	-7.6	-0.05	1.62	4.73	-
2025	-15.0	0.26	5.16	9.00	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2022	$-1.59	$25.92M	$-37.16M	-143.4%
2023	$-1.26	$45.23M	$-29.46M	-65.1%
2024	$-3.89	$65.44M	$-40.46M	-61.8%
2025	$-1.46	$89.06M	$-53.41M	-60%

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$-1.46	$-1.63 – $-1.35	$113.14M	$112.82M – $113.62M	7
2027	$-1.01	$-1.41 – $-0.69	$144.59M	$144.43M – $144.67M	7
2028	$-0.86	$-1.03 – $-0.76	$184.69M	$184.02M – $185.35M	3